Manufacturer record
Anra Pharamaceuticals Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Anra Pharamaceuticals Pvt Ltd was declared Not of Standard Quality in December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: IAL77/23, Chlorpheniramin e Maleate Injection (exp Nov 2025). King Institute Chennai (state lab) found it not of standard quality: Sample does not conform to the requirement for Assay for Chlorpheniramine. Listed in the December 2024 alert.
Records by type
1 record linked to Anra Pharamaceuticals Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Chlorpheniramin e Maleate Injection | Batch IAL77/23Mfg Dec 2023 · Exp Nov 2025 | Sample does not conform to the requirement for Assay for ChlorpheniramineAssay | King Institute ChennaiState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.